Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Blood|September 25, 2001
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosisS R Hayman, R J Bailey, S M Jalal, et al.
Leukemia|August 21, 2012
A phase III randomized trial of thalidomide plus zoledronic acid versus zoledronic acid alone in patients with asymptomatic multiple myelomaT E Witzig, K M Laumann, M Q Lacy, et al.
Leukemia|May 24, 2016
Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agentsN Majithia, S V Rajkumar, M Q Lacy, et al.
Leukemia|October 22, 2015
Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myelomaG P Kaufman, M A Gertz, A Dispenzieri, et al.
Kidney International|April 4, 2008
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chainsN Leung, M A Gertz, S R Zeldenrust, et al.
Blood Cancer Journal|June 17, 2017
Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myelomaP Ravi, S Kumar, W Gonsalves, et al.
Blood Cancer Journal|March 21, 2015
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myelomaW I Gonsalves, N Leung, S V Rajkumar, et al.
Leukemia|February 20, 2003
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myelomaC S Debes-Marun, G W Dewald, S Bryant, et al.
Blood Cancer Journal|July 30, 2016
Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myelomaP Ravi, S Kumar, J T Larsen, et al.
Heart (British Cardiac Society)|January 10, 2014
High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosisA Dispenzieri, M A Gertz, S K Kumar, et al.
Pageof 9